5-Bromo-2-methoxy-4-methyl-3-nitropyridine, 98.0%, 100g

2,5-Difluorobenzoic acid, 98.0%, 25g

(S)-2-(Aminomethyl)-3-methylbutanoic acid, 95.0%, 1g

4-Butylcyclohexylamine (cis- and trans- mixture)>98.0%(GC)(T)25mL

(cis-2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl methanesulfonate, 99.0%, 25g

(2-chloro-3,4-dimethoxyphenyl)acetonitrile, 5g

4-Fluorobenzonitrile>99.0%(GC)100g

(2S,3S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 50mg

4,7-Dibromoquinoline, 95.0%, 5g

S-Phenyl thioacetate, 98%, 5g

1H,1H,5H-Octafluoropentyl methacrylate, 97.0%, 100g

3-(2,4-Difluorophenoxy)azetidine hydrochloride, 98%, 50mg

Methyl 3-iodo-1H-pyrrolo[2,3-b]pyridine-4-carboxylate, 95.0%, 5g